Canrenone
| Clinical data | |
|---|---|
| Trade names | Contaren, Luvion, Phanurane, Spiroletan |
| Other names | Aldadiene; SC-9376; RP-11614; 7α-Desthioacetyl-δ6-spironolactone; 6,7-Dehydro-7α-desthioacetylspironolactone; 17-Hydroxy-3-oxo-17α-pregna-4,6-diene-21-carboxylic acid γ-lactone |
| AHFS/Drugs.com | International Drug Names |
| Drug class | Antimineralocorticoid |
| ATC code | |
| Pharmacokinetic data | |
| Protein binding | 95% |
| Elimination half-life | 16.5 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.012.322 |
| Chemical and physical data | |
| Formula | C22H28O3 |
| Molar mass | 340.463 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Canrenone, sold under the brand names Contaren, Luvion, Phanurane, and Spiroletan, is a steroidal antimineralocorticoid of the spirolactone group related to spironolactone which is used as a diuretic in Europe, including in Italy and Belgium. It is also an important active metabolite of spironolactone, and partially accounts for its therapeutic effects.